Literature DB >> 15665364

Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease.

S Aoki, H Mizote, A Minamoto, M Suzuki, H K Mishima, H Tanaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665364      PMCID: PMC1772496          DOI: 10.1136/bjo.2004.051391

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

1.  Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.

Authors:  Y Ogawa; S Okamoto; T Mori; M Yamada; Y Mashima; R Watanabe; M Kuwana; K Tsubota; Y Ikeda; Y Oguchi
Journal:  Bone Marrow Transplant       Date:  2003-04       Impact factor: 5.483

2.  Phase II study of FK 506 for allogeneic bone marrow transplantation.

Authors:  T Masaoka; H Shibata; E Kakishita; A Kanamaru; Y Takemoto; Y Moriyama
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  GVHD dry eyes treated with autologous serum tears.

Authors:  E M Rocha; F S Pelegrino; C S de Paiva; A C Vigorito; C A de Souza
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

4.  Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease.

Authors:  P T Murphy; M Sivakumaran; G Fahy; R M Hutchinson
Journal:  Bone Marrow Transplant       Date:  1996-09       Impact factor: 5.483

Review 5.  Management of graft-versus-host disease.

Authors:  S Arai; G B Vogelsang
Journal:  Blood Rev       Date:  2000-12       Impact factor: 8.250

6.  Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.

Authors:  Y Ogawa; S Okamoto; M Kuwana; T Mori; R Watanabe; T Nakajima; M Yamada; Y Mashima; K Tsubota; Y Oguchi
Journal:  Cornea       Date:  2001-05       Impact factor: 2.651

7.  Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.

Authors:  A Tichelli; T Duell; M Weiss; G Socié; P Ljungman; A Cohen; M van Lint; A Gratwohl; H J Kolb
Journal:  Bone Marrow Transplant       Date:  1996-06       Impact factor: 5.483

8.  The use of topical cyclosporin A in ocular graft-versus-host-disease.

Authors:  E Kiang; N Tesavibul; R Yee; J Kellaway; D Przepiorka
Journal:  Bone Marrow Transplant       Date:  1998-07       Impact factor: 5.483

  8 in total
  8 in total

Review 1.  Therapeutic Strategies to Treat Dry Eye in an Aging Population.

Authors:  Nisreen S Ezuddin; Karam A Alawa; Anat Galor
Journal:  Drugs Aging       Date:  2015-07       Impact factor: 3.923

2.  Ocular manifestations of graft-versus-host disease.

Authors:  Amr Nassar; Khalid F Tabbara; Mahmoud Aljurf
Journal:  Saudi J Ophthalmol       Date:  2013-07

Review 3.  Dry eye: an inflammatory ocular disease.

Authors:  Michelle Hessen; Esen Karamursel Akpek
Journal:  J Ophthalmic Vis Res       Date:  2014-04

4.  FK506 immunosuppression for submandibular salivary gland allotransplantation in rabbit.

Authors:  Akram Abdo Almansoori; Namuun Khentii; Kyung Won Ju; Bongju Kim; Soung Min Kim; Jong-Ho Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2020-06-30

5.  Impediment of selenite-induced cataract in rats by combinatorial drug laden liposomal preparation.

Authors:  Caixuan Huang; Cairui Li; Paerheti Muhemaitia
Journal:  Libyan J Med       Date:  2019-12       Impact factor: 1.657

Review 6.  Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics.

Authors:  Xinyuan Zhang; Lin Zhao; Shijing Deng; Xuguang Sun; Ningli Wang
Journal:  J Ophthalmol       Date:  2016-04-26       Impact factor: 1.909

7.  Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.

Authors:  Jialu Wang; Fang Zhao; Rui Liu; Jingjing Chen; Qinghua Zhang; Ruijuan Lao; Ze Wang; Xin Jin; Changxiao Liu
Journal:  Int J Nanomedicine       Date:  2017-11-06

Review 8.  Development and Characterization of Nanoemulsions for Ophthalmic Applications: Role of Cationic Surfactants.

Authors:  Ana R Fernandes; Elena Sanchez-Lopez; Tiago Dos Santos; Maria L Garcia; Amelia M Silva; Eliana B Souto
Journal:  Materials (Basel)       Date:  2021-12-08       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.